These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 33940011)

  • 21. Clinical Benefits and Safety of Medical Cannabis Products: A Narrative Review on Natural Extracts.
    Mick G; Douek P
    Pain Ther; 2024 Oct; 13(5):1063-1094. PubMed ID: 39096481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medicinal Applications of Cannabinoids Extracted from Cannabis sativa (L.): A New Route in the Fight Against COVID-19?
    Khalid S; Almalki FA; Hadda TB; Bader A; Abu-Izneid T; Berredjem M; Elsharkawy ER; Alqahtani AM
    Curr Pharm Des; 2021; 27(13):1564-1578. PubMed ID: 33267756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cannabidiol in medical marijuana: Research vistas and potential opportunities.
    Rong C; Lee Y; Carmona NE; Cha DS; Ragguett RM; Rosenblat JD; Mansur RB; Ho RC; McIntyre RS
    Pharmacol Res; 2017 Jul; 121():213-218. PubMed ID: 28501518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Constituents of Cannabis Sativa.
    Rock EM; Parker LA
    Adv Exp Med Biol; 2021; 1264():1-13. PubMed ID: 33332000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The medical use of cannabis for reducing morbidity and mortality in patients with HIV/AIDS.
    Lutge EE; Gray A; Siegfried N
    Cochrane Database Syst Rev; 2013 Apr; (4):CD005175. PubMed ID: 23633327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroprotection in Experimental Autoimmune Encephalomyelitis and Progressive Multiple Sclerosis by Cannabis-Based Cannabinoids.
    Pryce G; Riddall DR; Selwood DL; Giovannoni G; Baker D
    J Neuroimmune Pharmacol; 2015 Jun; 10(2):281-92. PubMed ID: 25537576
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medical cannabis and cannabinoids in rheumatology: where are we now?
    Sarzi-Puttini P; Batticciotto A; Atzeni F; Bazzichi L; Di Franco M; Salaffi F; Marotto D; Ceribelli A; Ablin JN; Hauser W
    Expert Rev Clin Immunol; 2019 Oct; 15(10):1019-1032. PubMed ID: 31512536
    [No Abstract]   [Full Text] [Related]  

  • 28. Marijuana use among patients with epilepsy at a tertiary care center.
    Kerr A; Walston V; Wong VSS; Kellogg M; Ernst L
    Epilepsy Behav; 2019 Aug; 97():144-148. PubMed ID: 31252269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cannabis and epilepsy: An ancient treatment returns to the fore.
    Russo EB
    Epilepsy Behav; 2017 May; 70(Pt B):292-297. PubMed ID: 27989385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cannabinoids in the Treatment of Epilepsy.
    Friedman D; Devinsky O
    N Engl J Med; 2015 Sep; 373(11):1048-58. PubMed ID: 26352816
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacology of Medical Cannabis.
    Amin MR; Ali DW
    Adv Exp Med Biol; 2019; 1162():151-165. PubMed ID: 31332738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Marijuana Use in Epilepsy: The Myth and the Reality.
    Detyniecki K; Hirsch L
    Curr Neurol Neurosci Rep; 2015 Oct; 15(10):65. PubMed ID: 26299273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cannabidiol pharmacotherapy for delta-9-tetrahidrocannabinol dependence].
    Pavlovsky F; Groisman R; Hurtado AK; García L
    Vertex; 2022 Oct; 33(157):34-43. PubMed ID: 36219190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medical use of cannabis products: Lessons to be learned from Israel and Canada.
    Ablin J; Ste-Marie PA; Schäfer M; Häuser W; Fitzcharles MA
    Schmerz; 2016 Feb; 30(1):3-13. PubMed ID: 26767992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cannabis and cannabinoids.
    Med Lett Drugs Ther; 2016 Aug; 58(1500):97-8. PubMed ID: 27466748
    [No Abstract]   [Full Text] [Related]  

  • 36. Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.
    Rosenberg EC; Patra PH; Whalley BJ
    Epilepsy Behav; 2017 May; 70(Pt B):319-327. PubMed ID: 28190698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo-controlled, randomised clinical trial of efficacy and safety of 1:1 delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD).
    Hardy J; Haywood A; Gogna G; Martin J; Yates P; Greer R; Good P
    Trials; 2020 Jul; 21(1):611. PubMed ID: 32631447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Translational hurdles with cannabis medicines.
    Graham M; Lucas CJ; Schneider J; Martin JH; Hall W
    Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1325-1330. PubMed ID: 32281186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The current status of artisanal cannabis for the treatment of epilepsy in the United States.
    Sulak D; Saneto R; Goldstein B
    Epilepsy Behav; 2017 May; 70(Pt B):328-333. PubMed ID: 28254350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cannabis, cannabidiol, and epilepsy--from receptors to clinical response.
    Szaflarski JP; Bebin EM
    Epilepsy Behav; 2014 Dec; 41():277-82. PubMed ID: 25282526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.